Radiolabeled Dendrimers for Nuclear Medicine Applications
AbstractRecent advances in nuclear medicine have explored nanoscale carriers for targeted delivery of various radionuclides in specific manners to improve the effect of diagnosis and therapy of diseases. Due to the unique molecular architecture allowing facile attachment of targeting ligands and radionuclides, dendrimers provide versatile platforms in this filed to build abundant multifunctional radiolabeled nanoparticles for nuclear medicine applications. This review gives special focus to recent advances in dendrimer-based nuclear medicine agents for the imaging and treatment of cancer, cardiovascular and other diseases. Radiolabeling strategies for different radionuclides and several challenges involved in clinical translation of radiolabeled dendrimers are extensively discussed. View Full-Text
Share & Cite This Article
Zhao, L.; Zhu, M.; Li, Y.; Xing, Y.; Zhao, J. Radiolabeled Dendrimers for Nuclear Medicine Applications. Molecules 2017, 22, 1350.
Zhao L, Zhu M, Li Y, Xing Y, Zhao J. Radiolabeled Dendrimers for Nuclear Medicine Applications. Molecules. 2017; 22(9):1350.Chicago/Turabian Style
Zhao, Lingzhou; Zhu, Meilin; Li, Yujie; Xing, Yan; Zhao, Jinhua. 2017. "Radiolabeled Dendrimers for Nuclear Medicine Applications." Molecules 22, no. 9: 1350.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.